Extracted from this filing and checked against the source text.
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
THERMO FISHER SCIENTIFIC INC. entered into Indenture (Base Indenture dated November 20, 2009 and Thirtieth Supplemental Indenture dated February 12, 2026) with The Bank of New York Mellon Trust Company, N.A. valued at $3.8 billion aggregate principal amount of senior notes with interest rates from 4.215% to 5.546% an (effective 2026-02-12).
- Action
- entry
- Agreement
- notes offering
- Counterparty
- The Bank of New York Mellon Trust Company, N.A.
- Value
- $3.8 billion aggregate principal amount of senior notes with interest rates from 4.215% to 5.546% an
- Effective
- 2026-02-12
Exact text from the filing
On February 12, 2026, Thermo Fisher Scientific Inc. (the “Company”) issued $1,000,000,000 aggregate principal amount of 4.215% Senior Notes due 2031 (the “2031 Notes”), $750,000,000 aggregate principal amount of 4.550% Senior Notes due 2033 (the “2033 Notes”), $1,300,000,000 aggregate principal amount of 4.902% Senior Notes due 2036 (the “2036 Notes”) and $750,000,000 aggregate principal amount of 5.546% Senior Notes due 2046 (the “2046 Notes” and, collectively with the 2031 Notes, the 2033 Notes and the 2036 Notes, the “Notes”) in a public offering (the “Offering”) pursuant to a registration statement on Form S-3ASR (File No. 333- 285159) and a preliminary prospectus supplement and prospectus supplement related to the offering of the Notes, each as previously filed with the Securities and Exchange Commission. The Notes were issued under an indenture, dated as of November 20, 2009 (the “Base Indenture”) and the Thirtieth Supplemental Indenture, dated as of February 12, 2026 (the “Suppl
View on SEC.gov